Co-Chairs

Paul Inman

Partner at Gowlings WLG (U.K)

Dr. Corinna Sundermann

Senior Vice President, Intellectual Property Management at Fresenius Kabi Deutschland GmbH (Germany)

Distinguished Speaker Faculty

Rob Aerts

Lead IP Evaluation at KWS Saat SE (Germany)

Dr. Sven J.R. Bostyn

Associate Professor of Biomedical Innovation Law at University of Copenhagen (Denmark)

Dr. Philip Cepl

Partner at DLA Piper (Germany)

Kristin Cooklin

Global Head of Patents at Zentiva (Czech Republic)

Karine Crepin

VP Global Head of Biologic Patents at Sanofi (France)

Fredrik Fredh

Senior Patent Attorney at Novartis (Switzerland)

Andreas Geissler

VP Intellectual Property at Leukocare AG (Germany)

Katherine Helm

Partner at Dechert (U.S.)

Martin Hufnal

Principal at Fish & Richardson

Bernd Hutter

Vice President, Head of Intellectual Property at MorphoSys (Germany)

Martin Jäger

Judge at German Federal Patent Court

John Kirkland

Director, IP & Litigation Counsel at Alkermes (U.S.)

Katherin Korner

Senior VP IP at Grunenthal GmbH (Germany)

Karin Pramberger

Intellectual Property Director at Polpharma Group

Scott Reed

Partner at Venable (U.S.)

Christoph Rehfuss

Head of IP at Sotio (Czech Republic)

Roberto Romandini

Member of the Board of Appeal at European Patent Office

Nicolas Ruiz

IP Director at Esteve Pharmaceuticals (Spain)
Alastair Sayce

Alastair Sayce

Head of Biologics IP at Teva Pharmaceuticals (Switzerland)

Jon Singer

Principal at Fish & Richardson (U.S.)

Dr. Ulrich Storz

Senior Partner at Michalski Huettermann Patent Attorneys (Germany)

Dean Thomas

Senior Director IP/Legal at Glenmark Pharmaceuticals

Rene Wagner

Senior Expert, Examiner at European Patent Office

Ha Kung Wong

Partner at Venable (U.S.)